535 related articles for article (PubMed ID: 31609073)
1. Outcomes of three different new generation transcatheter aortic valve prostheses.
Costa G; Buccheri S; Barbanti M; Picci A; Todaro D; Di Simone E; La Spina K; D'Arrigo P; Criscione E; Nastasi M; Sgroi C; Tamburino C
Catheter Cardiovasc Interv; 2020 Feb; 95(3):398-407. PubMed ID: 31609073
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter Aortic Valve Replacement With Next-Generation Self-Expanding Devices: A Multicenter, Retrospective, Propensity-Matched Comparison of Evolut PRO Versus Acurate neo Transcatheter Heart Valves.
Pagnesi M; Kim WK; Conradi L; Barbanti M; Stefanini GG; Zeus T; Pilgrim T; Schofer J; Zweiker D; Testa L; Taramasso M; Hildick-Smith D; Abizaid A; Wolf A; Van Mieghem NM; Sedaghat A; Wöhrle J; Khogali S; Van der Heyden JAS; Webb JG; Estévez-Loureiro R; Mylotte D; MacCarthy P; Brugaletta S; Hamm CW; Bhadra OD; Schäfer U; Costa G; Tamburino C; Cannata F; Reimers B; Veulemans V; Asami M; Windecker S; Eitan A; Schmidt A; Bianchi G; Bedogni F; Saccocci M; Maisano F; Alsanjari O; Siqueira D; Jensen CJ; Naber CK; Ziviello F; Sinning JM; Seeger J; Rottbauer W; Brouwer J; Alenezi A; Wood DA; Tzalamouras V; Regueiro A; Colombo A; Latib A
JACC Cardiovasc Interv; 2019 Mar; 12(5):433-443. PubMed ID: 30846081
[TBL] [Abstract][Full Text] [Related]
3. Performance of the Evolut-R 34 mm versus Sapien-3 29 mm in Transcatheter aortic valve replacement patients with larger annuli: Early outcome results of Evolut-R 34 mm as compared with Sapien-3 29 mm in patients with Annuli ≥26 mm.
Eitan A; Witt J; Stripling J; Haselbach T; Rieß FC; Schofer J
Catheter Cardiovasc Interv; 2018 Dec; 92(7):1374-1379. PubMed ID: 29521464
[TBL] [Abstract][Full Text] [Related]
4. Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis: Insights From the BEAT International Collaborative Registrys.
Mangieri A; Tchetchè D; Kim WK; Pagnesi M; Sinning JM; Landes U; Kornowski R; De Backer O; Nickenig G; Ielasi A; De Biase C; Søndergaard L; De Marco F; Montorfano M; Chiarito M; Regazzoli D; Stefanini G; Presbitero P; Toggweiler S; Tamburino C; Immè S; Tarantini G; Sievert H; Schäfer U; Kempfert J; Wöehrle J; Gallo F; Laricchia A; Latib A; Giannini F; Colombo A
Circ Cardiovasc Interv; 2020 Jul; 13(7):e008714. PubMed ID: 32646304
[TBL] [Abstract][Full Text] [Related]
5. Impact of device landing zone calcification patterns on paravalvular regurgitation after transcatheter aortic valve replacement with different next-generation devices.
Mauri V; Frohn T; Deuschl F; Mohemed K; Kuhr K; Reimann A; Körber MI; Schofer N; Adam M; Friedrichs K; Kuhn EW; Scholtz S; Rudolph V; Wahlers TCW; Baldus S; Mader N; Schäfer U; Rudolph TK
Open Heart; 2020 May; 7(1):. PubMed ID: 32393655
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli: The TAVI-SMALL Registry.
Regazzoli D; Chiarito M; Cannata F; Pagnesi M; Miura M; Ziviello F; Picci A; Reifart J; De Marco F; Bedogni F; Adamo M; Curello S; Teles R; Taramasso M; Barbanti M; Tamburino C; Stefanini GG; Mangieri A; Giannini F; Pagnotta PA; Maisano F; Kim WK; Van Mieghem NM; Colombo A; Reimers B; Latib A;
JACC Cardiovasc Interv; 2020 Jan; 13(2):196-206. PubMed ID: 31883714
[TBL] [Abstract][Full Text] [Related]
7. First North American experience with the transfemoral ACURATE-neo
Bagur R; Teefy PJ; Kiaii B; Diamantouros P; Chu MWA
Catheter Cardiovasc Interv; 2017 Jul; 90(1):130-138. PubMed ID: 27677241
[TBL] [Abstract][Full Text] [Related]
8. Early versus newer generation transcatheter heart valves for transcatheter aortic valve implantation: Echocardiographic and hemodynamic evaluation of an all-comers study cohort using the dimensionless aortic regurgitation index (AR-index).
Stundl A; Lucht H; Shamekhi J; Weber M; Sedaghat A; Mellert F; Grube E; Nickenig G; Werner N; Sinning JM
PLoS One; 2019; 14(5):e0217544. PubMed ID: 31150455
[TBL] [Abstract][Full Text] [Related]
9. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
Jatene T; Castro-Filho A; Meneguz-Moreno RA; Siqueira DA; Abizaid AAC; Ramos AIO; Arrais M; Le Bihan DCS; Barretto RBM; Moreira AC; Sousa AGMR; Eduardo Sousa J
Catheter Cardiovasc Interv; 2017 Jul; 90(1):139-146. PubMed ID: 28029207
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of the new generation transcatheter aortic valve in the real life studies. Review and meta-analysis.
Acconcia MC; Caretta Q; Monzo L; Tanzilli G; Sili Scavalli A; Sergi D; Di Luozzo M; Marchei M; Chiocchi M; Romeo F; Gaudio C
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8018-8027. PubMed ID: 31599427
[TBL] [Abstract][Full Text] [Related]
11. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve.
Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G
J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408
[TBL] [Abstract][Full Text] [Related]
12. Alignment of Transcatheter Aortic-Valve Neo-Commissures (ALIGN TAVR): Impact on Final Valve Orientation and Coronary Artery Overlap.
Tang GHL; Zaid S; Fuchs A; Yamabe T; Yazdchi F; Gupta E; Ahmad H; Kofoed KF; Goldberg JB; Undemir C; Kaple RK; Shah PB; Kaneko T; Lansman SL; Khera S; Kovacic JC; Dangas GD; Lerakis S; Sharma SK; Kini A; Adams DH; Khalique OK; Hahn RT; Søndergaard L; George I; Kodali SK; De Backer O; Leon MB; Bapat VN
JACC Cardiovasc Interv; 2020 May; 13(9):1030-1042. PubMed ID: 32192985
[TBL] [Abstract][Full Text] [Related]
13. Predictors of permanent pacemaker implantation after transcatheter aortic valve implantation for aortic stenosis using Medtronic new generation self-expanding CoreValve Evolut R.
Kaneko H; Hoelschermann F; Seifert M; Tambor G; Okamoto M; Moeller V; Neuss M; Butter C
Heart Vessels; 2019 Feb; 34(2):360-367. PubMed ID: 30083944
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial.
Lanz J; Kim WK; Walther T; Burgdorf C; Möllmann H; Linke A; Redwood S; Thilo C; Hilker M; Joner M; Thiele H; Conzelmann L; Conradi L; Kerber S; Schymik G; Prendergast B; Husser O; Stortecky S; Heg D; Jüni P; Windecker S; Pilgrim T;
Lancet; 2019 Nov; 394(10209):1619-1628. PubMed ID: 31570258
[TBL] [Abstract][Full Text] [Related]
15. Propensity-score-adjusted comparison of Evolut vs. Portico devices for transcatheter aortic valve implantation.
Giordano A; Corcione N; Ferraro P; Pieri P; Avellino R; Frati G; De Persio G; Altamura L; Tomai F; Biondi-Zoccai G
J Cardiovasc Med (Hagerstown); 2019 May; 20(5):351-357. PubMed ID: 30676494
[TBL] [Abstract][Full Text] [Related]
16. Bioprosthetic Valve Performance After Transcatheter Aortic Valve Replacement With Self-Expanding Versus Balloon-Expandable Valves in Large Versus Small Aortic Valve Annuli: Insights From the CHOICE Trial and the CHOICE-Extend Registry.
Abdelghani M; Mankerious N; Allali A; Landt M; Kaur J; Sulimov DS; Merten C; Sachse S; Mehilli J; Neumann FJ; Frerker C; Kurz T; El-Mawardy M; Richardt G; Abdel-Wahab M
JACC Cardiovasc Interv; 2018 Dec; 11(24):2507-2518. PubMed ID: 30503595
[TBL] [Abstract][Full Text] [Related]
17. Safety outcomes of new versus old generation transcatheter aortic valves.
Finkelstein A; Rozenbaum Z; Zhitomirsky S; Halkin A; Banai S; Bazan S; Barbash I; Segev A; Guetta V; Danenberg H; Planner D; Orvin K; Assa HV; Assali A; Kornowski R; Steinvil A
Catheter Cardiovasc Interv; 2019 Jul; 94(1):E44-E53. PubMed ID: 30549227
[TBL] [Abstract][Full Text] [Related]
18. Experience with the ACURATE neo and neo2 transcatheter aortic valves in Spain. The PRECISA (PRospective Evaluation Complementing Investigation with ACURATE devices) registry.
Tébar D; Carrillo X; García Del Blanco B; Gómez-Hospital JA; Nombela L; Molina E; Galeote G; Vilalta V; Serra-García V; Carol GM; Jiménez-Valero S; Fernandez-Nofrerias E; Calabuig-Goena Á; Jurado-Román A; Sánchez-Recalde Á; Velasco MF; Bosca L; Moreno R
Catheter Cardiovasc Interv; 2024 May; 103(6):1015-1022. PubMed ID: 38577931
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Edwards SAPIEN S3 Versus Medtronic Evolut-R Devices for Transcatheter Aortic Valve Implantation.
Ben-Shoshan J; Konigstein M; Zahler D; Margolis G; Chorin E; Steinvil A; Arbel Y; Aviram G; Granot Y; Barkagan M; Keren G; Halkin A; Banai S; Finkelstein A
Am J Cardiol; 2017 Jan; 119(2):302-307. PubMed ID: 28029363
[TBL] [Abstract][Full Text] [Related]
20. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
